Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rapid Nasal Breathing as a Biometric Trigger: High-Accuracy Electroencephalogram-Based Authentication for Clinical Applications.

The clinical respiratory journal·2026

Same author

Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendations.

Chinese medical journal pulmonary and critical care medicine·2026

Same author

Pulmonary Function Prediction Method Based on Convolutional Surface Modeling and Computational Fluid Dynamics Simulation.

Healthcare (Basel, Switzerland)·2025

Same author

A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial.

Nature medicine·2025

Same author

Potential influence of geomagnetic activity on blood pressure statistical fluctuations at mid-magnetic latitudes.

Communications medicine·2025

Same author

Exhaled breath acetone in predicting the presence and severity of respiratory failure.

Journal of breath research·2025

Search research articles

Related Experiment Video

Updated: Oct 29, 2025

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Pneumonia caused by Pseudomonas fluorescens: a case report.

Xiao Liu¹, Lei Xiang², Yunhong Yin³

¹Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.

BMC Pulmonary Medicine

|July 6, 2021

Summary

Pseudomonas fluorescens pneumonia is rare but treatable. This case highlights the first isolation of P. fluorescens from lung tissue, emphasizing timely antibiotic susceptibility testing for effective patient recovery.

Keywords:

Case report Fever Lung biopsy Pneumonia Pseudomonas fluorescens

More Related Videos

Pseudomonas aeruginosa Induced Lung Injury Model

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: Oct 29, 2025

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Pseudomonas aeruginosa Induced Lung Injury Model

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

Medical Microbiology
Pulmonology
Infectious Diseases

Background:

Pseudomonas fluorescens is typically found in respiratory samples.
No prior reports documented P. fluorescens cultures originating from lung tissues.

Observation:

A case of pneumonia caused by P. fluorescens is presented.
P. fluorescens was identified in lung biopsy specimens, marking a novel finding.
Antibiotic susceptibility testing guided treatment with ciprofloxacin.

Findings:

The patient's temperature normalized following ciprofloxacin treatment.
Chest CT scans indicated improvement in pulmonary inflammation.
Successful treatment of P. fluorescens pneumonia was achieved.

Implications:

This case underscores the importance of prompt diagnosis and treatment for P. fluorescens pneumonia.
Antibiotic susceptibility testing is crucial for selecting effective therapies.
Further research into P. fluorescens lung infections may be warranted.